Covidien PLC (COV)

106.71
1.36 1.26
Prev Close 108.07
Open 107.97
Day Low/High 106.71 / 108.16
52 Wk Low/High 65.97 / 108.57
Volume 24.76M
Avg Volume 3.84M
Exchange
Shares Outstanding 454.51M
Market Cap 48.50B
EPS 3.68
Div & Yield 1.44 (1.30%)

Latest News

Covalon Announces Receipt Of First Payment Under New License Agreement

Covalon Announces Receipt Of First Payment Under New License Agreement

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has received $3.

Covalon Announces Major Banking Milestone

Covalon Announces Major Banking Milestone

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that the Company has entered into a new acquisition and operating banking credit facility with HSBC Bank Canada...

Covalon Unaware Of Any Material Change

Covalon Unaware Of Any Material Change

At the request of the Investment Industry Regulatory Organization of Canada ("IIROC"), Covalon Technologies Ltd.

Covalon Announces Retirement Of Member Of Board Of Directors

Covalon Announces Retirement Of Member Of Board Of Directors

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announces that Martin Bernholtz has retired as a member of the Board of Directors of the Company, effective at the end of...

Covalon Technologies Ltd. To Exhibit At The Largest Annual Infection Prevention And Control Conference In The World

Covalon Technologies Ltd. To Exhibit At The Largest Annual Infection Prevention And Control Conference In The World

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will exhibit at the APIC 2018 Conference in Minneapolis, Minnesota, June 13 th to 15 th.

Covalon Announces Major Corporate Initiatives And Second Quarter Results

Covalon Announces Major Corporate Initiatives And Second Quarter Results

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced some major corporate initiatives and second quarter results.

Covalon To Host Conference Call To Discuss Release Of Q2 Results And Initiatives

Covalon To Host Conference Call To Discuss Release Of Q2 Results And Initiatives

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF) an advanced medical technologies company, has scheduled a conference call for Tuesday May 29 th 2018 at 9:00 am ET.

Covalon Announces Major Sales Breakthrough - Wins Contracts With An Estimated Value Of $100 Million Over A Three-Year Period

Covalon Announces Major Sales Breakthrough - Wins Contracts With An Estimated Value Of $100 Million Over A Three-Year Period

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has been informed that it has won a series of competitive contracts in the Middle East with an estimated sales value of $100...

Covalon To Showcase MediClear™ PreOp At AATS 2018 Annual Meeting

Covalon To Showcase MediClear™ PreOp At AATS 2018 Annual Meeting

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be showcasing its perioperative suite of innovative products, including MediClear™ PreOp, at the...

Covalon To Feature MediClear™ PreOp At AORN Surgical Conference And Expo 2018

Covalon To Feature MediClear™ PreOp At AORN Surgical Conference And Expo 2018

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be featuring its perioperative suite of innovative products including...

Covalon's MediClear™ PreOp Receives Frost & Sullivan's 2018 North American Surgical Site Infection Prevention New Product Innovation Award

Covalon's MediClear™ PreOp Receives Frost & Sullivan's 2018 North American Surgical Site Infection Prevention New Product Innovation Award

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today its MediClear™ PreOp has received Frost & Sullivan's 2018 North American...

Covalon Announces Its Participation In Medical Japan 2018

Covalon Announces Its Participation In Medical Japan 2018

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be participating in the Ontario Government's Life Sciences Trade...

Covalon Announces Strong First Quarter Financial Results

Covalon Announces Strong First Quarter Financial Results

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today its first quarter financial results.

Covalon Announces Issuance Of Stock Options

Covalon Announces Issuance Of Stock Options

Further to its press release dated October 27, 2017, Covalon Technologies Ltd.

US Major General Gale S. Pollock (Ret.) Joins Covalon's Board Of Directors

US Major General Gale S. Pollock (Ret.) Joins Covalon's Board Of Directors

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is extremely pleased to announce that Major General (Ret.

Covalon Announces Issuance Of Stock Options

Covalon Announces Issuance Of Stock Options

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the issuance of 60,000 stock options to financial advisors of the Company.

Covalon Announces Major Milestone: FDA Clearance For MediClear™ PreOp

Covalon Announces Major Milestone: FDA Clearance For MediClear™ PreOp

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today it has received United States Food and Drug Administration ("FDA") clearance to...

Covalon Announces The Commencement Of Trading On The OTCQX Market In The United States

Covalon Announces The Commencement Of Trading On The OTCQX Market In The United States

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF), an advanced medical technologies company, today announced that shares of the Company have commenced trading on the OTCQX® Best...

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

The recent bid by Mylan to acquire Perrigo offers the latest example of pharma companies that have been seeking growth opportunities.

Say It With Me: Specialty Pharma

These companies are the hottest thing going.

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Ikaria, which focuses on therapies for critically ill infants, is privately owned by a group led by Madison Dearborn Partners. Buyer Mallinckrodt specializes in diagnostic radiology and pain management.

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

After a robust year of mega-deals in 2014, mid-size device makers are expected to seek partners, fueling even further consolidation.

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Medtronic's $49.9 billion acquisition of Covidien -- the largest tax inversion deal ever -- will leave shareholders with a big tax bill, while Medtronic may pay little or no taxes.

Covidien Announces Effectiveness Of Medtronic Transaction Scheme Of Arrangement

Covidien Announces Effectiveness Of Medtronic Transaction Scheme Of Arrangement

Covidien plc (NYSE: COV) today announced, for purposes of the Irish Takeover Rules, that the scheme of arrangement under which Medtronic acquired Covidien under a new holding company incorporated in Ireland to be named...

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback

Stryker must significantly outperform for all of 2015 just to meet expectations. That's a tall order.

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the health services industry lower today.

Today Covidien (COV) Hits New Lifetime High

Today Covidien (COV) Hits New Lifetime High

Trade-Ideas LLC identified Covidien (COV) as a new lifetime high candidate

10 Stocks Billionaire John Paulson Loves: DirecTV, AbbVie and More

10 Stocks Billionaire John Paulson Loves: DirecTV, AbbVie and More

Here's a look at 10 stocks that Paulson & Co. bought in the most recently reported quarter.